Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Frascarelli

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Pharmacogenomics|March 5, 2024
<i>PIK3CA</i> testing in hormone receptor-positive/HER2-negative metastatic breast cancer: real-world data from Italian molecular pathology laboratoriesFrancesco Pepe, Konstantinos Venetis, Giulia Cursano, et al.
European Journal of Cancer (Oxford, England : 1990)|January 19, 2025
Mismatch repair (MMR) and microsatellite instability (MSI) phenotypes across solid tumors: A comprehensive cBioPortal study on prevalence and prognostic impactKonstantinos Venetis, Chiara Frascarelli, Luca Boscolo Bielo, et al.
Cancers|November 13, 2025
Artificial Intelligence in Thyroid Cytopathology: Diagnostic and Technical InsightsMariachiara Negrelli, Chiara Frascarelli, Fausto Maffini, et al.
Brain : a Journal of Neurology|March 2, 2023
Variants in ATP5F1B are associated with dominantly inherited dystoniaAlessia Nasca, Niccolò E Mencacci, Federica Invernizzi, et al.
Pathologica|April 9, 2026
<i>PIK3CA</i> testing in HR+/HER2- metastatic breast cancer: assessing pathology laboratories capacity and needsEltjona Mane, Giulia Cursano, Konstantinos Venetis, et al.
Breast Cancer Research : BCR|May 14, 2025
ESR1 testing on FFPE samples from metastatic lesions in HR + /HER2- breast cancer after progression on CDK4/6 inhibitor therapyKonstantinos Venetis, Giulia Cursano, Roberta Scafetta, et al.
Nature Communications|March 2, 2025
Multimodal histopathologic models stratify hormone receptor-positive early breast cancerKevin M Boehm, Omar S M El Nahhas, Antonio Marra, et al.
Critical Reviews in Oncology/Hematology|August 18, 2023
Advancing the PD-L1 CPS test in metastatic TNBC: Insights from pathologists and findings from a nationwide surveyNicola Fusco, Mariia Ivanova, Chiara Frascarelli, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Pharmacogenomics|March 5, 2024
<i>PIK3CA</i> testing in hormone receptor-positive/HER2-negative metastatic breast cancer: real-world data from Italian molecular pathology laboratoriesFrancesco Pepe, Konstantinos Venetis, Giulia Cursano, et al.
European Journal of Cancer (Oxford, England : 1990)|January 19, 2025
Mismatch repair (MMR) and microsatellite instability (MSI) phenotypes across solid tumors: A comprehensive cBioPortal study on prevalence and prognostic impactKonstantinos Venetis, Chiara Frascarelli, Luca Boscolo Bielo, et al.
Cancers|November 13, 2025
Artificial Intelligence in Thyroid Cytopathology: Diagnostic and Technical InsightsMariachiara Negrelli, Chiara Frascarelli, Fausto Maffini, et al.
Brain : a Journal of Neurology|March 2, 2023
Variants in ATP5F1B are associated with dominantly inherited dystoniaAlessia Nasca, Niccolò E Mencacci, Federica Invernizzi, et al.
Pathologica|April 9, 2026
<i>PIK3CA</i> testing in HR+/HER2- metastatic breast cancer: assessing pathology laboratories capacity and needsEltjona Mane, Giulia Cursano, Konstantinos Venetis, et al.
Breast Cancer Research : BCR|May 14, 2025
ESR1 testing on FFPE samples from metastatic lesions in HR + /HER2- breast cancer after progression on CDK4/6 inhibitor therapyKonstantinos Venetis, Giulia Cursano, Roberta Scafetta, et al.
Nature Communications|March 2, 2025
Multimodal histopathologic models stratify hormone receptor-positive early breast cancerKevin M Boehm, Omar S M El Nahhas, Antonio Marra, et al.
Critical Reviews in Oncology/Hematology|August 18, 2023
Advancing the PD-L1 CPS test in metastatic TNBC: Insights from pathologists and findings from a nationwide surveyNicola Fusco, Mariia Ivanova, Chiara Frascarelli, et al.
Pageof 3